Medicine
Case report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome
The paper
Jiangsu Province (Suqian) Hospital; Harbin Medical University
Medicine, 4 Sep 2026
Related
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity